Letters to the editorRepetitive levosimendan in outpatients affected by advanced heart failure: the need for a uniform approachMaiello, Ciroa; Cacciatore, Francescob; Amarelli, Cristianoa; Palmieri, Vittorioa; Golino, PaolocAuthor Information aDepartment of Cardiac Surgery and Transplantation, Heart Transplantation Unit in Adults of the ‘Ospedali dei Colli Monaldi-Cotugno-CTO’ bDepartment of Translational Medical Sciences and Internal Medicine and Geriatrics, ‘Federico II’ University of Naples cDepartment of Cardiology, Cardiology Unit of the ‘L. Vanvitelli’ University of Campania at the ‘Ospedali dei Colli Monaldi-Cotugno-CTO’, Naples, Italy Correspondence to Francesco Cacciatore, MD, PhD, Federico II University of Naples, 80131 Naples, Italy E-mail: [email protected] Received 16 June, 2020 Revised 6 July, 2020 Accepted 12 July, 2020 This letter refers to Masarone D, Valente F, Verrengia M, et al. Efficacy and safety of repeated infusion of levosimendan in outpatients with advanced heart failure: a realworld experience. J Cardiovasc Med (Hagerstown) 2020 Nov;21(11):919-921. Journal of Cardiovascular Medicine: February 2021 - Volume 22 - Issue 2 - p 149 doi: 10.2459/JCM.0000000000001090 Buy Metrics © 2020 Italian Federation of Cardiology - I.F.C. All rights reserved.